Intervention | Control | pvalue | |
---|---|---|---|
All Patients* (n) | 5560 | 5820 | |
Consenting Patients** (n) | 2858 | 2788 | |
Mean HbA1c at baseline (SD)** | 7.11 (0.43) | 7.19 (0.52) | 0.32 |
Mean years since T2DM diagnosis (SD)** | 7.9 (2.54) | 8.0 (2.90) | 0.80 |
Mean number of insulin-eligible patients at time of workshop per physician (n,%) | 10.9 (5.80) | 11.3 (7.09) | 0.70 |
Mean HbA1c of insulin-eligible patients at time of workshop (SD)** | 8.6 (0.59) | 8.6 (0.76) | 0.74 |
Mean number of patients newly prescribed insulin between Workshop and 12 months post (SD)** | 1.8 (1.87) | 1.9 (1.71) | 0.91 |
Mean number of office visits during study for insulin-eligible patients at the time of insulin initiation (SD) | 6.0 (2.24) | 5.9 (2.39) | 0.84 |
Mean elapsed time in days, workshop to first office visit for insulin-eligible patients at the time of insulin initiation (SD) | 45.3 (32.92) | 65.4 (53.99) | 0.04 |